BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 18329957)

  • 21. 14-3-3 proteins as potential oncogenes.
    Tzivion G; Gupta VS; Kaplun L; Balan V
    Semin Cancer Biol; 2006 Jun; 16(3):203-13. PubMed ID: 16725345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
    Kim KY; Baek A; Hwang JE; Choi YA; Jeong J; Lee MS; Cho DH; Lim JS; Kim KI; Yang Y
    Cancer Res; 2009 May; 69(9):4018-26. PubMed ID: 19366811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of 5-HT1A receptor-dependent cell survival by cAMP/protein kinase A: role of protein phosphatase 2A and Bax.
    Hsiung SC; Tin A; Tamir H; Franke TF; Liu KP
    J Neurosci Res; 2008 Aug; 86(10):2326-38. PubMed ID: 18459133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
    Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
    Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of PP2A complexes and pathways involved in cell transformation.
    Sablina AA; Hector M; Colpaert N; Hahn WC
    Cancer Res; 2010 Dec; 70(24):10474-84. PubMed ID: 21159657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
    Chen L; Liu L; Yin J; Luo Y; Huang S
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
    Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
    FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
    Chan G; Kalaitzidis D; Neel BG
    Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of proteins interacting with the catalytic subunit of PP2A by proteomics.
    Lee WJ; Kim DU; Lee MY; Choi KY
    Proteomics; 2007 Jan; 7(2):206-14. PubMed ID: 17163575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of specific PP2A complexes involved in human cell transformation.
    Chen W; Possemato R; Campbell KT; Plattner CA; Pallas DC; Hahn WC
    Cancer Cell; 2004 Feb; 5(2):127-36. PubMed ID: 14998489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein phosphatase 4--from obscurity to vital functions.
    Cohen PT; Philp A; Vázquez-Martin C
    FEBS Lett; 2005 Jun; 579(15):3278-86. PubMed ID: 15913612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical association of GPR54 C-terminal with protein phosphatase 2A.
    Evans BJ; Wang Z; Mobley L; Khosravi D; Fujii N; Navenot JM; Peiper SC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1067-71. PubMed ID: 18977201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.
    Zhao J; Wu HW; Chen YJ; Tian HP; Li LX; Han X; Guo J
    J Neurosci Res; 2008 Sep; 86(12):2733-45. PubMed ID: 18478546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.
    Jackson JB; Pallas DC
    Neoplasia; 2012 Jul; 14(7):585-99. PubMed ID: 22904676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein.
    Liu SL; Miller AD
    Oncogene; 2007 Feb; 26(6):789-801. PubMed ID: 16909114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serine/threonine phosphatases: mechanism through structure.
    Shi Y
    Cell; 2009 Oct; 139(3):468-84. PubMed ID: 19879837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
    Carratù MR; Signorile A; De Rasmo D; Reale A; Vacca A
    Curr Med Chem; 2016; 23(38):4286-4296. PubMed ID: 27758717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40.
    Chen Y; Xu Y; Bao Q; Xing Y; Li Z; Lin Z; Stock JB; Jeffrey PD; Shi Y
    Nat Struct Mol Biol; 2007 Jun; 14(6):527-34. PubMed ID: 17529992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1.
    Kaur A; Westermarck J
    Biochem Soc Trans; 2016 Dec; 44(6):1683-1693. PubMed ID: 27913678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.